By Keck Medicine of US – SciTechDaily –
A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.
In Parkinson’s disease, the problem starts deep in the brain, where a small group of cells gradually fails. The condition is progressive and affects more than one million people in the United States, with roughly 90,000 new diagnoses each year. Today’s treatments can make symptoms easier to live with, but there is still no cure and no therapy proven to slow the underlying disease.
